Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine
Authors:
- Svein Rune AndersenSASvein Rune Andersen
- Rolf DalsegRDRolf Dalseg
- Signe DrømtorpSDSigne Drømtorp
- Johan HolstJHJohan Holst
- Ellen NamorkENEllen Namork
- Elisabeth WedegeEWElisabeth Wedege
- Bjørn HanebergBHBjørn Haneberg
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Epithelial M Cells: Gateways for Mucosal Infection and ImmunizationCell, 1996
- Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxinVaccine, 1996
- Human immune responses to influenza virus vaccines administered by systemic or mucosal routesVaccine, 1995
- Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomesVaccine, 1995
- New strategies for using mucosal vaccination to achieve more effective immunizationVaccine, 1994
- Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in miceVaccine, 1993
- Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccineEuropean Journal of Immunology, 1992
- Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccinationVaccine, 1990
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- Interaction of Neisseria meningitidis with Human Nasopharyngeal Mucosa: Attachment and Entry into Columnar Epithelial CellsThe Journal of Infectious Diseases, 1983